Alphatec Holdings Accounts Receivables 2011-2026 | ATEC

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.

Examples of accounts receivable

Customers have not paid invoices for delivered products
An advance has been paid to a supplier, but goods have not yet been received
Employees have not reported on accountable amounts
The government must refund tax overpayments
Outstanding loans issued

Importance of accounts receivable in company analysis

Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)

Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)

If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables Alphatec Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
97.3 M	83 M	72.6 M	60.1 M	41.9 M	23.5 M	16.2 M	15.1 M	14.8 M	18.5 M	38.3 M	40.4 M	41.4 M	41 M	41.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
97.3 M	14.8 M	43.1 M

Quarterly Accounts Receivables Alphatec Holdings

2026-Q1	2025-Q4	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
106 M	97.3 M	95.9 M	89.5 M	83 M	78.5 M	84 M	88.6 M	72.6 M	64.5 M	59.9 M	62.4 M	60.1 M	50.7 M	-	40.4 M	41.9 M	33.7 M	33.7 M	25.8 M	23.5 M	23.5 M	23.5 M	23.5 M	16.2 M	16.2 M	16.2 M	16.2 M	15.1 M	15.1 M	15.1 M	15.1 M	14.8 M	14.8 M	14.8 M	14.8 M	18.5 M	18.5 M	18.5 M	18.5 M	26.9 M	26.9 M	38.3 M	38.3 M	40.4 M	40.4 M	40.4 M	40.4 M	41.4 M	41.4 M	41.4 M	41.4 M	41 M	41 M	41 M	41 M	41.7 M	41.7 M	41.7 M	41.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
106 M	14.8 M	40.8 M

Accounts Receivables of other stocks in the Medical devices industry

Issuer	Accounts Receivables	Price	% 24h	Market Cap	Country
Avinger AVGR	1.01 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	57.2 M	-	-	$ 3.31 B	USA
Allied Healthcare Products AHPI	2.37 M	-	3.58 %	$ 2.21 M	USA
ClearPoint Neuro CLPT	6.55 M	$ 11.53	-1.45 %	$ 326 M	USA
Apollo Endosurgery APEN	15 M	-	-	$ 475 M	USA
Aziyo Biologics AZYO	1.73 M	-	1.37 %	$ 20.5 M	USA
EDAP TMS S.A. EDAP	18.6 M	$ 4.35	-1.14 %	$ 163 M	France
BioSig Technologies BSGM	109 K	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	5.48 M	-	-13.19 %	$ 166 K	USA
Conformis CFMS	9.77 M	-	-	$ 16.4 M	USA
LivaNova PLC LIVN	216 M	$ 74.1	0.62 %	$ 4.04 B	Britain
LENSAR LNSR	6.38 M	$ 6.04	1.51 %	$ 72.2 M	USA
Cardiovascular Systems CSII	39.7 M	-	0.15 %	$ 844 M	USA
Helius Medical Technologies HSDT	70 K	$ 2.3	-2.54 %	$ 50.7 M	USA
Cytosorbents Corporation CTSO	7.55 M	$ 0.46	0.11 %	$ 28.6 M	USA
OrthoPediatrics Corp. KIDS	53.8 M	$ 18.56	0.71 %	$ 435 M	USA
Delcath Systems DCTH	11.7 M	$ 11.35	-0.87 %	$ 407 M	USA
Profound Medical Corp. PROF	7.2 M	$ 6.94	-0.43 %	$ 210 M	Canada
IRIDEX Corporation IRIX	7.61 M	$ 1.03	2.48 %	$ 17.4 M	USA
Dynatronics Corporation DYNT	2.8 M	-	14.99 %	$ 929 K	USA
Eargo EAR	1.91 M	-	-	$ 10.2 M	USA
MiMedx Group MDXG	75.7 M	$ 3.64	0.69 %	$ 538 M	USA
Pulmonx Corporation LUNG	12.1 M	$ 1.58	2.6 %	$ 64.3 M	USA
Electromed ELMD	24.7 M	$ 38.32	-0.69 %	$ 324 M	USA
Myomo MYO	4.1 M	$ 1.07	12.66 %	$ 44.8 M	USA
Butterfly Network BFLY	26.7 M	$ 4.41	-1.45 %	$ 1.09 B	USA
Second Sight Medical Products EYES	455 K	-	-0.97 %	$ 54.4 M	USA
Sintx Technologies SINT	178 K	$ 2.42	5.22 %	$ 6.71 M	USA
Orthofix Medical OFIX	136 M	$ 10.71	2.88 %	$ 424 M	Curacao
GBS GBS	595 K	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	679 M	$ 85.2	0.73 %	$ 11.5 B	USA
Insulet Corporation PODD	141 M	$ 154.1	-1.78 %	$ 10.8 B	USA
TransMedics Group TMDX	84.3 M	$ 68.37	-0.7 %	$ 2.32 B	USA
CONMED Corporation CNMD	248 M	$ 37.35	0.86 %	$ 1.16 B	USA
Inspire Medical Systems INSP	120 M	$ 43.16	-3.64 %	$ 1.27 B	USA
Integer Holdings Corporation ITGR	346 M	$ 89.73	-0.28 %	$ 3.12 B	USA
Invacare Corporation IVC	88 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	660 M	$ 84.71	1.81 %	$ 49.5 B	USA